The STRN-ALK fusion is a genetic alteration implicated in thyroid cancer, leading to the downregulation of sodium-iodide symporter (NIS), a key factor in radioactive iodine (RAI) refractoriness. This evidence concerns the gene STRN and thyroid gland carcinoma.